'White coat hypertension' in adolescents: Increased values of urinary cortisol and endothelin

Journal of Pediatrics

Volumn 136, Issue 3, 2000, Pages 359-364

  Vaindirlis, Iraklis ^a   Peppa Patrikiou, Melpomeni ^a   Dracopoulou, Maria ^a   Manoli, Irini ^a   Voutetakis, Antonis ^a   Dacou Voutetakis, Catherine ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ENDOTHELIN; RENIN;

ADOLESCENT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; NEPHELOMETRY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; WHITE COAT HYPERTENSION;

EID: 0033942523     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.103410     Document Type: Article

References (49)

1. 1. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood pressure measurements by the doctor on patient's blood pressure and heart rate. Lancet 1983;2: 695-8.
2. 2. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurements by physician and nurse. Hypertension 1987;9:209-15.
3. 3. Pickering TG. The clinical applications of ambulatory blood pressure monitoring: the white coat syndrome. Clin Invest Med 1991;14:212-7.
4. 4. Mancia G, Zanchetti A. White coat hypertension: misnomers, misconceptions and misunderstandings: What should we do next? J Hypertens 1996;14:1049-52.
5. 5. Lantelme P, Milon H, Gharib C, Gayet C, Fortrat JO. White coat effect and reactivity to stress. Cardiovascular and autonomic nervous system responses. Hypertension 1998:31:1021-9.
6. 6. Hornsby JL, Morgan PF, Taylor AT, Treiber FA. White coat hypertension in children. J Fam Pract 1991:33:617-23.
7. 7. Von Eiff AW, Gogolin E, Jacobs U, Neus H. Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension. Clin Exp Hypertens (A) 1986:129:577-81.
8. 8. Julius S, Jamerson K, Gudbrandsson T, Schork N. White coat hypertension: a follow-up. Clin Exp Hypertens 1992; 14:45-53.
9. 9. Gosse P, Promax H, Durandet P, Clementy J. White coat hypertension: no harm for the heart. Hypertension 1993;22:766-70.
10. 10. Pellegrino L, Prencipe G. White coat hypertension and isolated systolic hypertension: ultrasonography of the carotid arteries. G Ital Cardiol 1997; 27:443-9
11. 11. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white coat hypertension. J Hypertens 1995;12:1707-10.
12. 12. Cavallini MC, Roman MJ, Pickering TG, Scwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricle hypertrophy? Hypertension 1995; 26:413-9.
13. 13. Julius S, Mejia A, Jones K, Krause L, Schork N, Van de Ven C, et al. White coat versus sustained borderline hypertension in Tecumseh, Michigan. Hypertension 1990;16:617-23.
14. 14. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993;22:826-31.
15. 15. Burnier M, Biollez J, Magnin JL, Bidlingmeyer M, Brunner HR. Renal sodium handling in patients with untreated hypertension and WCH. Hypertension 1994;23:496-502.
16. 16. Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end organ changes in WCH. Hypertension 1993;21:836-44.
17. 17. Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm S. Microalbuminuria in 411 untreated individuals with established hypertension white coat hypertension and normotension. Hypertension 1994;24:101-5.
18. 18. Nalbantgil I, Onder R, Nalbantgil S, Yilmaz H, Boydak B. The prevalence of silent myocardial ischaemia in patients with white-coat hypertension. J Hum Hypertens 1998;12:337-41.
19. 19. Peppa-Patrikiou AI, Dracopoulou M, Dacou-Voutetakis C. Urinary endothelin in adolescents and young adults with insulin dependent diabetes mellitus. Relation to urinary albumin, blood pressure and other factors. Metabolism 1998;47:1408-12.
20. 20. Task Force on Blood Pressure Control in Children (1987). Report of The Second Task Force on Blood Pressure Control in Children. Pediatrics 1987; 79:1-25.
21. 21. Burns TL, Moll PP, Lauer RM. Increased familial cardiovascular mortality in obese schoolchildren: the Muscatine Ponderosity Family Study. Pediatrics 1992;89:262-8.
22. 22. Kjeidsen SF, Moon A, Rostrop M, Nordby G, Os I, Fide I. White coat hypertension and blood pressure measurement at home. Zidsskr Nov Laegeforen 1993;113:1839-43.
23. 23. Sineiko R. Hypertension in children. N Engl J Med 1996;26:1968-75.
24. 24. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649-58.
25. 25. Dacou Voutetakis C, Patrikiou-Peppa M, Dracopoulou M. Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM. Relation to endothelin-1 and indices of diabetic angiopathy. J Pediatr Endocrinol Metab 1998;1:43-5.
26. 26. Abassi ZA, Klein H, Coolomb E, Keiser HR. Urinary endothelin: a possible biological marker of renal damage. Am J Hypertens 1993;6:1046-54.
27. 27. Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, et al. Urinary excretion of. ET1 in normal subjects and patients with renal disease. Kidney Int 1991;39:307-11.
28. 28. Hall JE, Guyton AC. The kidney and regulation of blood pressure. In: Luscher TF, Kaplan NM, editors. Renovascular and renal parenchymatous hypertension. Heidelberg (Germany): Springer-Verlag; 1992. p. 2-29.
29. 29. Kon V, Badr KF. Biological actions and pathophysiological significance of endothelin in the kidney. Kidney Int 1991;40:1-12.
30. 30. Kristensen KS, Bang LE, Hoegholm A, Nielsen JW, Holm S. Albuminuria in persons with real hypertension, white coat hypertension and normotension. Ugeskr Laeger 1995;157: 3322-5.
31. 31. Bang LE, Holm J, Svendsen TL. Retinol binding protein and transferrin in urine. New markers of renal function in essential hypertension and white coat hypertension. Am J Hypertens 1996;9:1024-8.
32. 32. Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993;342:589-93.
33. 33. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;88:614-8.
34. 34. Schiffrin E. Endothelin in hypertension. Curr Opin Cardiol 1995;10:485-94.
35. 35. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Cray GA, et al. Pathophysiological role of endothelin revealed by the first orally active receptor antagonist. Nature 1993;365:759-61.
36. 36. Krum H, Viskoper R, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med 1998;338:784-90.
37. 37. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;11:383-90.
38. 38. Onizuka M, Miyauchi T, Mitsui K, Suzuki N, Masaki T, Goto K, et al. Endothelin-1 mediates regional blood flow during and after pulmonary operations. J Thorac Cardiovasc Surg 1992;104:1696-7.
39. 39. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen T, Rosenlof K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun 1990; 169:217-21.
40. 40. Miyauchi T, Sugisita Y, Yamaguchi I, Ajisaka R, Tomizawa T, Onizuka M, et al. Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans. J Cardiovasc Pharmacol 1992;17(Suppl 7):S394-7.
41. 41. Rossi GP, Albertin G, Neri G, Andreis PG, Hofman S, Pessina AC, et al. Endothelin-1 stimulates steroid secretion of human adrenocortical cells ex vivo via both ETA and ETB receptor subtypes. J Clin Endocrinol Metab 1997; 82:3445-9.
42. 42. Hinson JP, Vinson GP, Kapas S, Teja R. The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin 1 and endothelin 3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol 1991;128:275-9.
43. 43. Krukoff TL, MacTavish D, Jhamandas JH. Hypertensive rats exhibit heightened expression of corticotropin-releasing factor in activated central neurons in response to restraint stress. Brain Res Mol Brain Res 1999; 19;65:70-9.
44. 44. Imaki T, Naruse M, Harada S, Chikada N, Nakajima K, Yoshimoto T, et al. Stress-induced changes of gene expression in the paraventricular nucleus are enhanced in spontaneously hypertensive rats. J Neuroendocrinol 1998; 10:635-43.
45. 45. Fuchs LC, Iandas SK, Johnson AK. Behavioral stress alters coronary vascular reactivity in borderline hypertensive rats. J Hypertens 1997;15:301-7.
46. 46. Nystrom F, Aardal E, Ohman KP. A population based study of the white coat blood pressure effect: positive correlation with plasma cortisol. Clin Exp Hypertens 1998;20:95-104.
47. 47. Muneta S, Kobayashi T, Matsumoto I. Personality characteristics of patients with "white coat" hypertension. Hypertens Res 1997;20:99-104.
48. 48. Weber MA, Nentel JM, Smith DH, Graettinger WS. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994;90: 2291-8.
49. 49. Chang NC, Lai ZY, Chan P, Wang TC. Left ventricular filling profiles in young white-coat hypertensive patients without hypertrophy. Hypertension 1997;30:746-52.